Disclosures for "Rituximab in CNS Sarcoidosis: A Multi-center Retrospective Series"
-
Dr. El Sammak has nothing to disclose.
-
Dr. Herman has nothing to disclose.
-
Mr. Nakirikanti has nothing to disclose.
-
Dr. Bou has nothing to disclose.
-
Dr. Rohm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono.
-
Dr. Pawate has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Pawate has received research support from Genentech. The institution of Dr. Pawate has received research support from Biogen.
-
The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH.
-
Dr. Vargas has nothing to disclose.
-
Dr. Hutto has nothing to disclose.